董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bradley L. Radoff | 男 | Director | 51 | 21.88万美元 | 未持股 | 2024-11-22 |
| Jon Couchman | 男 | Director | 55 | 未披露 | 未持股 | 2024-11-22 |
| Steven J. Pully | 男 | Director and Chairman of the Board | 64 | 20.40万美元 | 未持股 | 2024-11-22 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kara Cannon | 女 | Chief Executive Officer | 56 | 99.94万美元 | 未持股 | 2024-11-22 |
| Patricia Eckert | 女 | Chief Financial Officer | 47 | 49.00万美元 | 未持股 | 2024-11-22 |
| Brian Fisher | 男 | General Counsel, Secretary | 54 | 未披露 | 未持股 | 2024-11-22 |
董事简历
中英对照 | 中文 | 英文- Bradley L. Radoff
-
Bradley L. Radoff自2022年1月起担任公司董事。Radoff先生目前是公司审计委员会的主席，也是公司提名和治理委员会及薪酬委员会的成员。Radoff先生是一名私人投资者，自2005年以来还担任私人投资管理公司Fondren Management LP的负责人。Radoff先生曾于2006年至2009年在注册投资咨询公司Third Point LLC担任投资组合经理。2003年至2004年，他还担任注册投资咨询公司Lonestar Capital Management LLC的董事总经理。Radoff先生还曾于2000年至2003年担任全球金融机构Citadel Investment Group LLC的董事。Radoff先生自2020年6月起担任总部位于德克萨斯州的独立能源公司VAALCO Energy, Inc.（纽约证券交易所代码：EGY）的董事，并自2021年5月起担任全球领先的客户体验公司Harte Hanks, Inc.（纳斯达克股票代码：HHS）的董事。Radoff先生曾于2016年6月至2021年9月担任Support.com, Inc.（前纳斯达克股票代码：SPRT）和Pogo Producing Company（前纽约证券交易所股票代码：PPP）（一家石油和天然气勘探、开发和生产公司）的董事，该公司于2007年3月至2007年11月完成向Plains Exploration & Production Company的出售。Radoff先生以优异的成绩毕业于宾夕法尼亚大学沃顿商学院，获得经济学学士学位。
Bradley L. Radoff has served on Board since 2022 and currently serves as a private investor. Mr. Radoff served as Principal of Fondren Management LP, a private investment management company, from 2005 to December 2021. Mr. Radoff previoly served as a Portfolio Manager at Third Point LLC, a registered investment advisory firm, from 2006 to 2009. He also served as Managing Director of Lonestar Capital Management LLC, a registered investment advisory firm, from 2003 to 2004. Mr. Radoff also previoly served as a director of Citadel Investment Group LLC, a global financial institution, from 2000 to 2003. Mr. Radoff has served as a director of Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics, clinical lab and life sciences company, since January 2022, where he also serves as Chair of the Audit Committee. Mr. Radoff has served as a director of Harte Hanks, Inc. (NASDAQ: HHS), a leading global ctomer experience company, since May 2021. Mr. Radoff previoly served as a director of VAALCO Energy, Inc. (NYSE: EGY), a Texas based independent energy company, from June 2020 to January 2022, Support.com, Inc. (formerly NASDAQ: SPRT), a leading provider of cloud based software and services, from June 2016 until its merger in September 2021, and Pogo Producing Company (formerly NYSE: PPP), an oil and gas exploration, development and production company, from March 2007 until the completion of its sale to Plains Exploration & Production Company in November 2007. Mr. Radoff graduated summa cum laude with a B.S. in Economics from The Wharton School at the University of Pennsylvania. - Bradley L. Radoff自2022年1月起担任公司董事。Radoff先生目前是公司审计委员会的主席，也是公司提名和治理委员会及薪酬委员会的成员。Radoff先生是一名私人投资者，自2005年以来还担任私人投资管理公司Fondren Management LP的负责人。Radoff先生曾于2006年至2009年在注册投资咨询公司Third Point LLC担任投资组合经理。2003年至2004年，他还担任注册投资咨询公司Lonestar Capital Management LLC的董事总经理。Radoff先生还曾于2000年至2003年担任全球金融机构Citadel Investment Group LLC的董事。Radoff先生自2020年6月起担任总部位于德克萨斯州的独立能源公司VAALCO Energy, Inc.（纽约证券交易所代码：EGY）的董事，并自2021年5月起担任全球领先的客户体验公司Harte Hanks, Inc.（纳斯达克股票代码：HHS）的董事。Radoff先生曾于2016年6月至2021年9月担任Support.com, Inc.（前纳斯达克股票代码：SPRT）和Pogo Producing Company（前纽约证券交易所股票代码：PPP）（一家石油和天然气勘探、开发和生产公司）的董事，该公司于2007年3月至2007年11月完成向Plains Exploration & Production Company的出售。Radoff先生以优异的成绩毕业于宾夕法尼亚大学沃顿商学院，获得经济学学士学位。
- Bradley L. Radoff has served on Board since 2022 and currently serves as a private investor. Mr. Radoff served as Principal of Fondren Management LP, a private investment management company, from 2005 to December 2021. Mr. Radoff previoly served as a Portfolio Manager at Third Point LLC, a registered investment advisory firm, from 2006 to 2009. He also served as Managing Director of Lonestar Capital Management LLC, a registered investment advisory firm, from 2003 to 2004. Mr. Radoff also previoly served as a director of Citadel Investment Group LLC, a global financial institution, from 2000 to 2003. Mr. Radoff has served as a director of Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics, clinical lab and life sciences company, since January 2022, where he also serves as Chair of the Audit Committee. Mr. Radoff has served as a director of Harte Hanks, Inc. (NASDAQ: HHS), a leading global ctomer experience company, since May 2021. Mr. Radoff previoly served as a director of VAALCO Energy, Inc. (NYSE: EGY), a Texas based independent energy company, from June 2020 to January 2022, Support.com, Inc. (formerly NASDAQ: SPRT), a leading provider of cloud based software and services, from June 2016 until its merger in September 2021, and Pogo Producing Company (formerly NYSE: PPP), an oil and gas exploration, development and production company, from March 2007 until the completion of its sale to Plains Exploration & Production Company in November 2007. Mr. Radoff graduated summa cum laude with a B.S. in Economics from The Wharton School at the University of Pennsylvania.
- Jon Couchman
-
Jon Couchman，成为公司董事及公司审核委员会、提名及管治委员会及薪酬委员会成员，自2024年11月22日起生效。Couchman先生是Couchman Management LLC的管理成员，这是一家投资管理公司，他通过该公司管理私人投资。Couchman先生自2006年2月4日起担任XStelos Holdings，Inc.及其前身公司Footstar，Inc.的董事会主席。Couchman先生在重组并从中成功脱颖而出后成为董事会主席。2008年12月9日，Couchman先生成为富仕达的首席清盘官，并于2009年1月被任命为总裁兼首席执行官，以及首席财务官，自2009年8月开始。作为首席重组官，Couchman先生负责监督Footstar的清算和剩余资产的分配。随后，在2011年4月，Couchman先生监督了XStelos对上市制药公司CPEX Pharmaceuticals，Inc.的收购。Couchman先生自2013年1月22日起担任Myrexis，Inc.的董事兼首席执行官，自2013年3月1日起担任其首席财务官。Couchman先生自2014年11月26日起担任Affymax，Inc.的董事、首席执行官兼首席财务官。Couchman先生是一位重要股东，并于2007年12月14日被选为美国高尔夫信托公司（Golf Trust of America）的董事，该公司后来被称为Pernix Therapeutics。Golf Trust参与了出售其高尔夫球场持股的战略审查程序，并于2010年3月8日完成了与Pernix Therapeutics的反向合并。通过Couchman Capital LLC和Couchman Management LLC，Couchman先生从2001年至今担任Couchman Investments LP的普通合伙人和投资经理，从2001年至2013年担任Couchman Partners LP的私人投资合伙公司，从2001年至2013年担任私人合伙公司Couchman International Ltd.的投资经理。他拥有加州州立大学奇科分校的金融理学学士学位，并于1996年获得特许金融分析师称号（C.F.A.）。他曾在多个慈善委员会任职，并与家人居住在纽约市。
Jon Couchman,became a director of the Company and member of the Company's Audit Committee, Nominating & Governance Committee and Compensation Committee effective November 22, 2024. Mr. Couchman is the Managing Member of Couchman Management LLC, an investment management company through which he manages private investments. Mr. Couchman has served as Chairman of the Board of Xstelos Holdings, Inc. and its predecessor company Footstar, Inc., beginning February 4, 2006. Mr. Couchman became Chairman of the Board following its reorganization and successful emergence therefrom. On December 9, 2008, Mr. Couchman became Chief Wind-Down Officer of Footstar and in January 2009, was appointed President and Chief Executive Officer, and Chief Financial Officer, beginning August 2009. In his capacity as Chief Restructuring Officer, Mr. Couchman oversaw Footstar's liquidation and distribution of its remaining assets. Subsequently, in April 2011, Mr. Couchman oversaw Xstelos' acquisition of CPEX Pharmaceuticals, Inc., a publicly traded pharmaceutical company. Mr. Couchman has served as a Director and Chief Executive Officer of Myrexis, Inc. since January 22, 2013 and as its Chief Financial Officer since March 1, 2013. Mr. Couchman has served as a director, Chief Executive Officer and Chief Financial Officer of Affymax, Inc. since November 26, 2014. Mr. Couchman was a significant shareholder and was elected as a director of Golf Trust of America, subsequently known as Pernix Therapeutics on December 14, 2007. Golf Trust engaged in a strategic review process selling its golf course holdings and completed a reverse merger with Pernix Therapeutics on March 8, 2010. Through Couchman Capital LLC and Couchman Management LLC, Mr. Couchman has served as the general partner and investment manager of Couchman Investments LP from 2001 until present, Couchman Partners LP, private investment partnerships from 2001 until 2013 and the investment manager of Couchman International Ltd., a private partnership, from 2001 until 2013. He holds a Bachelor of Science in Finance from the California State University at Chico and received the Chartered Financial Analyst designation (C.F.A.) in 1996. He has served on several charitable boards and resides with his family in New York City. - Jon Couchman，成为公司董事及公司审核委员会、提名及管治委员会及薪酬委员会成员，自2024年11月22日起生效。Couchman先生是Couchman Management LLC的管理成员，这是一家投资管理公司，他通过该公司管理私人投资。Couchman先生自2006年2月4日起担任XStelos Holdings，Inc.及其前身公司Footstar，Inc.的董事会主席。Couchman先生在重组并从中成功脱颖而出后成为董事会主席。2008年12月9日，Couchman先生成为富仕达的首席清盘官，并于2009年1月被任命为总裁兼首席执行官，以及首席财务官，自2009年8月开始。作为首席重组官，Couchman先生负责监督Footstar的清算和剩余资产的分配。随后，在2011年4月，Couchman先生监督了XStelos对上市制药公司CPEX Pharmaceuticals，Inc.的收购。Couchman先生自2013年1月22日起担任Myrexis，Inc.的董事兼首席执行官，自2013年3月1日起担任其首席财务官。Couchman先生自2014年11月26日起担任Affymax，Inc.的董事、首席执行官兼首席财务官。Couchman先生是一位重要股东，并于2007年12月14日被选为美国高尔夫信托公司（Golf Trust of America）的董事，该公司后来被称为Pernix Therapeutics。Golf Trust参与了出售其高尔夫球场持股的战略审查程序，并于2010年3月8日完成了与Pernix Therapeutics的反向合并。通过Couchman Capital LLC和Couchman Management LLC，Couchman先生从2001年至今担任Couchman Investments LP的普通合伙人和投资经理，从2001年至2013年担任Couchman Partners LP的私人投资合伙公司，从2001年至2013年担任私人合伙公司Couchman International Ltd.的投资经理。他拥有加州州立大学奇科分校的金融理学学士学位，并于1996年获得特许金融分析师称号（C.F.A.）。他曾在多个慈善委员会任职，并与家人居住在纽约市。
- Jon Couchman,became a director of the Company and member of the Company's Audit Committee, Nominating & Governance Committee and Compensation Committee effective November 22, 2024. Mr. Couchman is the Managing Member of Couchman Management LLC, an investment management company through which he manages private investments. Mr. Couchman has served as Chairman of the Board of Xstelos Holdings, Inc. and its predecessor company Footstar, Inc., beginning February 4, 2006. Mr. Couchman became Chairman of the Board following its reorganization and successful emergence therefrom. On December 9, 2008, Mr. Couchman became Chief Wind-Down Officer of Footstar and in January 2009, was appointed President and Chief Executive Officer, and Chief Financial Officer, beginning August 2009. In his capacity as Chief Restructuring Officer, Mr. Couchman oversaw Footstar's liquidation and distribution of its remaining assets. Subsequently, in April 2011, Mr. Couchman oversaw Xstelos' acquisition of CPEX Pharmaceuticals, Inc., a publicly traded pharmaceutical company. Mr. Couchman has served as a Director and Chief Executive Officer of Myrexis, Inc. since January 22, 2013 and as its Chief Financial Officer since March 1, 2013. Mr. Couchman has served as a director, Chief Executive Officer and Chief Financial Officer of Affymax, Inc. since November 26, 2014. Mr. Couchman was a significant shareholder and was elected as a director of Golf Trust of America, subsequently known as Pernix Therapeutics on December 14, 2007. Golf Trust engaged in a strategic review process selling its golf course holdings and completed a reverse merger with Pernix Therapeutics on March 8, 2010. Through Couchman Capital LLC and Couchman Management LLC, Mr. Couchman has served as the general partner and investment manager of Couchman Investments LP from 2001 until present, Couchman Partners LP, private investment partnerships from 2001 until 2013 and the investment manager of Couchman International Ltd., a private partnership, from 2001 until 2013. He holds a Bachelor of Science in Finance from the California State University at Chico and received the Chartered Financial Analyst designation (C.F.A.) in 1996. He has served on several charitable boards and resides with his family in New York City.
- Steven J. Pully
-
Steven J. Pully，自2023年10月26日起担任公司董事、董事会主席和审计委员会主席，自2023年11月21日起担任公司薪酬委员会和提名与治理委员会成员。他是Speyside Partners（他于2017年5月共同创立的投资银行公司）的合伙人。他还在多家公司担任董事会或行政职务，包括上市公司RumbleOn, Inc.（纳斯达克股票代码：RMBL），担任执行主席。他的董事会服务跨越多个行业，包括航空公司、游乐园、能源和电力、制造业、电力体育、零售、餐馆和技术，并担任董事会主席或首席董事的多个职位，以及审计、薪酬、提名和治理和特别委员会的多个主席。此前，他曾担任投资公司Carlson Capital, L.P.的总法律顾问和合伙人（2008年至2014年），美国银行（Bank of America）投资银行部董事总经理，贝尔斯登公司（Bear Stearns & Company）投资银行部高级董事总经理。在过去的五年中，他曾担任以下上市公司的董事会成员：valalco Energy（纽约证券交易所代码：EGY）、Goodrich Petroleum、Bellatrix Exploration、Harvest Oil and Gas和Titan Energy。在公司根据破产法第11章申请破产之前，他在过去五年中被任命为以下私人公司董事会的独立董事：limmetree Bay Refinery、Southland Royalty和GenCanna Global。他目前在另一家私人公司Heritage Power的董事会任职，最初应公司贷方的要求被任命为董事会成员，之后该公司申请破产。最近，在遗产公司摆脱破产后，他被该公司的一位新股东再次任命为董事会成员。他在德克萨斯州持有活跃的法律和注册会计师执照，他是特许金融分析师，他还持有各种FINRA执照。
Steven J. Pully,has been a director of the Company, Chairman of the Board and Chairman of the Audit Committee since October 26, 2023. Mr. Pully also became a member of the Company's Compensation Committee and its Nominating & Governance Committee on November 21, 2023, and subsequently became Chairman of both Committees on January 31, 2024. Mr. Pully is a partner of Speyside Partners, an investment banking firm that he co-founded in May 2017. He also serves on the boards or in executive positions for various companies, including publicly-traded RumbleOn, Inc. (NASDAQ:RMBL). Previously, Mr. Pully worked for two different hedge funds and for various large investment banks. Within the past five years, Mr. Pully has served on the boards of the following public companies: VAALCO Energy (NYSE: EGY), Goodrich Petroleum, Bellatrix Exploration, Harvest Oil and Gas and Titan Energy. Mr. Pully holds active law and CPA licenses in the State of Texas, he is a Chartered Financial Analyst and he also holds various FINRA licenses. - Steven J. Pully，自2023年10月26日起担任公司董事、董事会主席和审计委员会主席，自2023年11月21日起担任公司薪酬委员会和提名与治理委员会成员。他是Speyside Partners（他于2017年5月共同创立的投资银行公司）的合伙人。他还在多家公司担任董事会或行政职务，包括上市公司RumbleOn, Inc.（纳斯达克股票代码：RMBL），担任执行主席。他的董事会服务跨越多个行业，包括航空公司、游乐园、能源和电力、制造业、电力体育、零售、餐馆和技术，并担任董事会主席或首席董事的多个职位，以及审计、薪酬、提名和治理和特别委员会的多个主席。此前，他曾担任投资公司Carlson Capital, L.P.的总法律顾问和合伙人（2008年至2014年），美国银行（Bank of America）投资银行部董事总经理，贝尔斯登公司（Bear Stearns & Company）投资银行部高级董事总经理。在过去的五年中，他曾担任以下上市公司的董事会成员：valalco Energy（纽约证券交易所代码：EGY）、Goodrich Petroleum、Bellatrix Exploration、Harvest Oil and Gas和Titan Energy。在公司根据破产法第11章申请破产之前，他在过去五年中被任命为以下私人公司董事会的独立董事：limmetree Bay Refinery、Southland Royalty和GenCanna Global。他目前在另一家私人公司Heritage Power的董事会任职，最初应公司贷方的要求被任命为董事会成员，之后该公司申请破产。最近，在遗产公司摆脱破产后，他被该公司的一位新股东再次任命为董事会成员。他在德克萨斯州持有活跃的法律和注册会计师执照，他是特许金融分析师，他还持有各种FINRA执照。
- Steven J. Pully,has been a director of the Company, Chairman of the Board and Chairman of the Audit Committee since October 26, 2023. Mr. Pully also became a member of the Company's Compensation Committee and its Nominating & Governance Committee on November 21, 2023, and subsequently became Chairman of both Committees on January 31, 2024. Mr. Pully is a partner of Speyside Partners, an investment banking firm that he co-founded in May 2017. He also serves on the boards or in executive positions for various companies, including publicly-traded RumbleOn, Inc. (NASDAQ:RMBL). Previously, Mr. Pully worked for two different hedge funds and for various large investment banks. Within the past five years, Mr. Pully has served on the boards of the following public companies: VAALCO Energy (NYSE: EGY), Goodrich Petroleum, Bellatrix Exploration, Harvest Oil and Gas and Titan Energy. Mr. Pully holds active law and CPA licenses in the State of Texas, he is a Chartered Financial Analyst and he also holds various FINRA licenses.
高管简历
中英对照 | 中文 | 英文- Kara Cannon
Kara Cannon是该公司首席商务官，自2011年以来一直受雇于该公司。她负责运营的战略和战术营销、销售、制造和综合管理。Cannon女士曾在颇尔公司担任执行职务，在那里她专注于诊断、生物技术和生物科学领域的商业运营。她也曾担任Dynal Biotech公司（现为Thermofisher Scientific公司）的营销和技术职务。她拥有丰富的经验，涉及诊断市场创新平台的营销和销售，以及诊断相关业务的增长和可持续性的战略计划的开发和执行。Cannon女士拥有Franklin and Marshall College的文学学士学位。
Kara Cannon,became a director and Chief Executive Officer on January 31, 2024. Prior to that, she was Interim Chief Executive Officer and Chief Operating Officer and has been employed with the Company since 2011. She is responsible for strategic and tactical marketing, sales, manufacturing and general management of the operations. Ms. Cannon previously held executive positions at Pall Corporation, where she focused on commercial operations within the areas of diagnostics, biotechnology and biosciences. She has also held marketing and technical positions at Dynal Biotech (now ThermoFisher Scientific). She has had extensive experience in the marketing and selling of innovative platforms for the diagnostics markets, as well as the development and execution of strategic plans for the growth and sustainability of diagnostic-related businesses. Ms. Cannon holds a BA from Franklin and Marshall College.- Kara Cannon是该公司首席商务官，自2011年以来一直受雇于该公司。她负责运营的战略和战术营销、销售、制造和综合管理。Cannon女士曾在颇尔公司担任执行职务，在那里她专注于诊断、生物技术和生物科学领域的商业运营。她也曾担任Dynal Biotech公司（现为Thermofisher Scientific公司）的营销和技术职务。她拥有丰富的经验，涉及诊断市场创新平台的营销和销售，以及诊断相关业务的增长和可持续性的战略计划的开发和执行。Cannon女士拥有Franklin and Marshall College的文学学士学位。
- Kara Cannon,became a director and Chief Executive Officer on January 31, 2024. Prior to that, she was Interim Chief Executive Officer and Chief Operating Officer and has been employed with the Company since 2011. She is responsible for strategic and tactical marketing, sales, manufacturing and general management of the operations. Ms. Cannon previously held executive positions at Pall Corporation, where she focused on commercial operations within the areas of diagnostics, biotechnology and biosciences. She has also held marketing and technical positions at Dynal Biotech (now ThermoFisher Scientific). She has had extensive experience in the marketing and selling of innovative platforms for the diagnostics markets, as well as the development and execution of strategic plans for the growth and sustainability of diagnostic-related businesses. Ms. Cannon holds a BA from Franklin and Marshall College.
- Patricia Eckert
Patricia Eckert是临时Chief Financial Officer，自2017年起受雇于公司，担任多个财务职务。Eckert女士以前曾在Pall公司担任会计主管，在该公司担任过多个会计和财务职务，最终管理着一支庞大的团队，并直接领导ASC 606收入确认标准实施的各个方面，监督与SOX合规有关的事项，并推动多项业务和财务成本节约举措。在Pall公司任职之前，Eckert女士曾在纽约一家中型会计师事务所担任高级会计师。她以优异的成绩毕业于纽约州亨普斯特德的霍夫斯特拉大学，获得会计学学士学位和金融学MBA学位。
Patricia Eckert,has served as Chief Financial Officer since January 31, 2024 and was interim Chief Financial Officer from November 14, 2022 until January 31, 2024. Ms. Eckert has been employed with the Company since 2017 in various finance roles. She is responsible for corporate finance strategy, global accounting and financial operations, SEC reporting, SOX compliance, and financial planning and analysis. Ms. Eckert previously served as accounting director at Pall Corporation, where she advanced through multiple accounting and finance roles, focusing on accounting operations, finance transformation, and project management. Prior to her tenure at Pall Corporation, Ms. Eckert served as senior accountant at a midsize accounting firm based in New York. She is a CPA, and graduated cum laude with a BBA in accounting and an MBA in finance, both from Hofstra University.- Patricia Eckert是临时Chief Financial Officer，自2017年起受雇于公司，担任多个财务职务。Eckert女士以前曾在Pall公司担任会计主管，在该公司担任过多个会计和财务职务，最终管理着一支庞大的团队，并直接领导ASC 606收入确认标准实施的各个方面，监督与SOX合规有关的事项，并推动多项业务和财务成本节约举措。在Pall公司任职之前，Eckert女士曾在纽约一家中型会计师事务所担任高级会计师。她以优异的成绩毕业于纽约州亨普斯特德的霍夫斯特拉大学，获得会计学学士学位和金融学MBA学位。
- Patricia Eckert,has served as Chief Financial Officer since January 31, 2024 and was interim Chief Financial Officer from November 14, 2022 until January 31, 2024. Ms. Eckert has been employed with the Company since 2017 in various finance roles. She is responsible for corporate finance strategy, global accounting and financial operations, SEC reporting, SOX compliance, and financial planning and analysis. Ms. Eckert previously served as accounting director at Pall Corporation, where she advanced through multiple accounting and finance roles, focusing on accounting operations, finance transformation, and project management. Prior to her tenure at Pall Corporation, Ms. Eckert served as senior accountant at a midsize accounting firm based in New York. She is a CPA, and graduated cum laude with a BBA in accounting and an MBA in finance, both from Hofstra University.
- Brian Fisher
Brian Fisher，自2024年5月起担任总法律顾问，自2024年8月15日起担任秘书，负责与公司有关的所有法律事务。在加入公司之前，Fisher先生曾在Tenerity，Inc.的法律部门担任过多种职务，包括在过去十年担任其总法律顾问。在此之前，Fisher先生是Akin，Gump，Strauss，Hauer & Feld，LLP和Sidley Austin LLP的公司律师。Fisher先生拥有纽约大学法学院法学博士学位和哈佛大学经济学A.B.学位。
Brian Fisher,has served as General Counsel since May 2024 and Secretary since August 15, 2024 and is responsible for all legal matters pertaining to the Company. Before joining the Company, Mr. Fisher served in a variety of roles within the legal department of Tenerity, Inc., including as its general counsel for the last ten years. Prior to that, Mr. Fisher was a corporate attorney for Akin, Gump, Strauss, Hauer & Feld, LLP and Sidley Austin LLP. Mr. Fisher holds a Juris Doctor from New York University School of Law and an A.B. degree in economics from Harvard University.- Brian Fisher，自2024年5月起担任总法律顾问，自2024年8月15日起担任秘书，负责与公司有关的所有法律事务。在加入公司之前，Fisher先生曾在Tenerity，Inc.的法律部门担任过多种职务，包括在过去十年担任其总法律顾问。在此之前，Fisher先生是Akin，Gump，Strauss，Hauer & Feld，LLP和Sidley Austin LLP的公司律师。Fisher先生拥有纽约大学法学院法学博士学位和哈佛大学经济学A.B.学位。
- Brian Fisher,has served as General Counsel since May 2024 and Secretary since August 15, 2024 and is responsible for all legal matters pertaining to the Company. Before joining the Company, Mr. Fisher served in a variety of roles within the legal department of Tenerity, Inc., including as its general counsel for the last ten years. Prior to that, Mr. Fisher was a corporate attorney for Akin, Gump, Strauss, Hauer & Feld, LLP and Sidley Austin LLP. Mr. Fisher holds a Juris Doctor from New York University School of Law and an A.B. degree in economics from Harvard University.